Patient Story: René, a retired GP from France, got the answers he needed about his coronary health

An increased calcium score with no stenosis of concern, what would you do next?

René is a retired GP from the south of France. He has coronary artery disease and was concerned about his risk of a heart attack since his calcium score from the CT scan showed an increase. Dr Tavildari then performed the CaRi-Heart® Analysis from Caristo Diagnostics to check René’s coronary inflammation levels.

“I strongly recommend this analysis to all my friends who have a coronary concern – René 

Watch this video to see what the results were and how the analysis helped René get the answers he needed about his coronary health

CaRi-Heart technology is Caristo’s flagship offering which aids coronary artery disease diagnosis with improved risk prediction. It applies advanced AI algorithms to routine cardiac CT scans to visualize and quantify coronary inflammation, which is the previously invisible root cause of the disease. Each patient’s CaRi-Heart Report includes several clinical results:

• the patient specific Fat Attenuation Index (FAI), a novel and patented biomarker for the measurement of coronary inflammation, which indicates the patient’s risk in % relative to a matched peer group;
• CaRi-Heart Risk, which assesses the absolute 8-year risk of a fatal heart attack (based on both coronary inflammation status and standard clinical risks factors); and
• coronary plaque-specific characterization and quantification.

The CaRi-Heart Analysis is supported by the CaRi-Heart software, which is cloud-based and agnostic to the type of scanner generating the routine cardiac CT images. The CaRi-Heart technology is CE Mark certified under the latest EU MDR with UKCA marking being received in September 2022.